EZH2 and gastric cancer: Studies have shown that lncRNAXIST was over-expressed in gastric cancer, which can be as a molecular sponge to modulate EZH2 expression by sponging miR-101 and it has been suggested possibly participating in the progression of gastric cancer[11].